Header Logo

Connection

CHELLAKKAN BLESSON to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications CHELLAKKAN BLESSON has written about Xenograft Model Antitumor Assays.
CHELLAKKAN BLESSON
Connection Strength
0.089
Xenograft Model Antitumor Assays
  1. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors a- and ?-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Steroids. 2013 Nov; 78(11):1071-86.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.